Greenville Health System Institute for Translational Oncology Research is a clinical research site located in Greenville, South Carolina, United States 29605.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Greenville Health System Institute for Translational Oncology Research has participated in 1 clinical trials.
Therapeutic areas: Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial.
Sponsors: Amgen.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Greenville Health System Institute for Translational Oncology Research has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Greenville Health System Institute for Translational Oncology Research has 1 clinical trials on record. Their work covers Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial.
Greenville Health System Institute for Translational Oncology Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.